The Patent Finder
US

Beta- and Gamma-Diketones and Gamma-Hydroxyketones as Wnt/Beta-Catenin Signaling Pathway Activators

US 8,609,717 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Sep 14, 2022 (Vickers Venture Fund VI Pte. Ltd.).

Term ends Nov 18, 2031 · High confidence

Filed Aug 17, 2011 as application 13/211,665 · Granted Dec 17, 2013
Base term plus 93 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2011 2031
Clock starts
Aug 17, 2011
Term ends
Nov 18, 2031
Granted
Dec 17, 2013
base term patent term adjustment fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
93
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 93 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 17, 2011, when this application, 13/211,665, was filedAug 17, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+93 days, USPTO patent term adjustment recordNov 18, 2031High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderNov 18, 2031High confidence

This family

US 8,609,717this patent
Nov 2031
Nov 2031
US 8,629,176Lapsed on the fee record
Jan 2026
Jan 2026
US 8,921,413In force
Aug 2031
Aug 2031
US 9,303,010In force
Aug 2031
Aug 2031
US 9,493,437In force
Aug 2031
Aug 2031
US 9,884,053Lapsed on the fee record
Feb 2026
Feb 2026
US 10,314,832In force
Aug 2031
Aug 2031
Application 16/430,741Abandoned
not computed
not computed
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 10, 2011
Reel 27036, frame 295
Kc, Sunil Kumar; Wallace, David Mark; Hood, John; Barroga, Charlene F.Wintherix LLCAssignment of Assignor's Interest
Jun 26, 2012
Reel 28442, frame 313
Wintherix, LLCSamumed, LLCMerger
Mar 23, 2021
Reel 55693, frame 882
Samumed, LLCBiosplice Therapeutics, Inc.Assignment of Assignor's Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers Venture Fund VI Pte. Ltd.Security Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers Venture Fund VI (Plan) Pte. Ltd.Security Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Vickers-Splice Co.-Investment LLCSecurity Interest
Sep 14, 2022
reel/frame not recorded
Biosplice Therapeutics, Inc.Med-Pathways II LimitedSecurity Interest
Sep 14, 2022
Reel 61433, frame 786
Biosplice Therapeutics, Inc.Vickers Venture Fund VI Pte. Ltd.; Vickers Venture Fund VI (Plan) Pte. Ltd.; Vickers-Splice Co.-Investment LLC; Med-Pathways II LimitedSecurity Interest
Mar 12, 2026
Reel 75109, frame 434
TMF Group New York, LLC, Not Individually But Solely as Collateral AgentBiosplice Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited